Protein-protein interactions by influenza polymerase subunits as drug targets
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Future medicinal chemistry - 14(2022), 2 vom: 01. Jan., Seite 53-56 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Felicetti, Tommaso [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 21.02.2022 Date Revised 21.02.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.4155/fmc-2021-0259 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM332681858 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM332681858 | ||
003 | DE-627 | ||
005 | 20231225220049.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.4155/fmc-2021-0259 |2 doi | |
028 | 5 | 2 | |a pubmed24n1108.xml |
035 | |a (DE-627)NLM332681858 | ||
035 | |a (NLM)34730024 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Felicetti, Tommaso |e verfasserin |4 aut | |
245 | 1 | 0 | |a Protein-protein interactions by influenza polymerase subunits as drug targets |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 21.02.2022 | ||
500 | |a Date Revised 21.02.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Editorial | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
650 | 4 | |a RNA-dependent RNA polymerase | |
650 | 4 | |a antiviral agents | |
650 | 4 | |a drug design | |
650 | 4 | |a influenza virus | |
650 | 4 | |a protein–protein interaction | |
650 | 7 | |a Antiviral Agents |2 NLM | |
650 | 7 | |a Enzyme Inhibitors |2 NLM | |
650 | 7 | |a Protein Subunits |2 NLM | |
650 | 7 | |a RNA-Dependent RNA Polymerase |2 NLM | |
650 | 7 | |a EC 2.7.7.48 |2 NLM | |
700 | 1 | |a Massari, Serena |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Future medicinal chemistry |d 2009 |g 14(2022), 2 vom: 01. Jan., Seite 53-56 |w (DE-627)NLM194822109 |x 1756-8927 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2022 |g number:2 |g day:01 |g month:01 |g pages:53-56 |
856 | 4 | 0 | |u http://dx.doi.org/10.4155/fmc-2021-0259 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2022 |e 2 |b 01 |c 01 |h 53-56 |